Pesquisas alternativas:
daily compared » early compared (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
nacl compared » acl compared (Expandir a Pesquisa), small compared (Expandir a Pesquisa), gel compared (Expandir a Pesquisa)
compared case » compared can (Expandir a Pesquisa), companies case (Expandir a Pesquisa), comparing case (Expandir a Pesquisa)
do computers » do computer (Expandir a Pesquisa), how computers (Expandir a Pesquisa), des computers (Expandir a Pesquisa)
computers a » computers _ (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
case now » cases now (Expandir a Pesquisa), case non (Expandir a Pesquisa), case new (Expandir a Pesquisa)
a daily » _ daily (Expandir a Pesquisa)
3 nacl » _ nacl (Expandir a Pesquisa), m nacl (Expandir a Pesquisa), 3.5 nacl (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), _ now (Expandir a Pesquisa), a nos (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
i do » e do (Expandir a Pesquisa), i d (Expandir a Pesquisa), _ do (Expandir a Pesquisa)
daily compared » early compared (Expandir a Pesquisa), elderly compared (Expandir a Pesquisa)
nacl compared » acl compared (Expandir a Pesquisa), small compared (Expandir a Pesquisa), gel compared (Expandir a Pesquisa)
compared case » compared can (Expandir a Pesquisa), companies case (Expandir a Pesquisa), comparing case (Expandir a Pesquisa)
do computers » do computer (Expandir a Pesquisa), how computers (Expandir a Pesquisa), des computers (Expandir a Pesquisa)
computers a » computers _ (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
case now » cases now (Expandir a Pesquisa), case non (Expandir a Pesquisa), case new (Expandir a Pesquisa)
a daily » _ daily (Expandir a Pesquisa)
3 nacl » _ nacl (Expandir a Pesquisa), m nacl (Expandir a Pesquisa), 3.5 nacl (Expandir a Pesquisa)
a now » a new (Expandir a Pesquisa), _ now (Expandir a Pesquisa), a nos (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
i do » e do (Expandir a Pesquisa), i d (Expandir a Pesquisa), _ do (Expandir a Pesquisa)
61
Por N. S. Rodionova, E. S. Popov, D. I. Matveev, E. S. Pevtsova, A. V. Sokolova, A. A. Diakov
Publicado em 2019-07-01
Assuntos:
“...vegetable biocorrectors, flour products, differential scanning calorimetry, thermogravimetry, non...”Publicado em 2019-07-01
Obter o texto integral
Artigo
62
“... compared to a diet based on concentrate mixture and wheat straw. METHODS: In exp. 1, 24 male lambs of about...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
63
“... administered alternately in two three-month periods. Weight loss on a 1,200-calorie diet was greater...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
64
“...Forty two Malpura lambs (21 d old) were divided into three groups of 14 each consisting of 8...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
65
“... integrity over a broad geographic range, and have contrasting mating systems. We compared reproductive...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
66
SILVER NANOPARTICLES IN THE SOLUTION OF THE PROBLEM OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
“... by an electrochemical method. With a size of 5-60 nm, 120-270 kontsentratsiey- 1 mcm² and the size of the stabilizer...”Obter o texto integral
Artigo
67
“...A clinical study of 96 patients compared a new hydrocolloid dressing (Granuflex Extra Thin) with a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
68
Por HERNÁNDEZ-VALERO, MARÍA A., THOMSON, CYNTHIA A., HERNÁNDEZ, MIKE, TRAN, TAYLOR, DETRY, MICHELLE A., THERIAULT, RICHARD L., HAJEK, RICHARD A., PIERCE, JOHN P., FLATT, SHIRLEY W., CAAN, BETTE J., JONES, LOVELL A.
Publicado em 2008
“... cancer survivors age-matched to 165 non-Hispanic white breast cancer survivors diagnosed with Stage I, II...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
69
Por Schwarting, A, Dooley, M A, Roth, D A, Edwards, L, Thompson, A, Wilson, B
Publicado no Lupus (2016)
“... compared with placebo (64.3% vs 78.1%; hazard ratio 0.64; 95% confidence interval: 0.42–0.96...”Publicado no Lupus (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
70
Por Gambaryan, P.Y., Kondrasheva, I.G., Severin, E.S., Guseva, A.A., Kamensky, A.A.
Publicado em 2014
“...To compare the efficacy of L-DOPA administered intranasally in the form of nanoparticles (nano-DOPA...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
71
Por N. S. Karamnova, S. A. Maksimov, S. A. Shalnova, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, A. V. Kapustina, S. E. Evstifeeva, O. M. Drapkina
Publicado em 2019-11-01
“... more protective diet compared to people with a low educational status.ESSE-RF study participants...”Publicado em 2019-11-01
Obter o texto integral
Artigo
72
Por Azar, S. T., Echtay, A., Wan Bebakar, W. M., Al Araj, S., Berrah, A., Omar, M., Mutha, A., Tornøe, K., Kaltoft, M. S., Shehadeh, N.
Publicado no Diabetes Obes Metab (2016)
“...AIMS: Compare effects of liraglutide 1.8 mg and sulphonylurea, both combined with metformin...”Publicado no Diabetes Obes Metab (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
73
Por Mahmoodpoor, A., Eslami, K., Mojtahedzadeh, M., Najafi, A., Ahmadi, A., Dehnadi-Moghadam, A., Mohammadirad, A., Baeeri, M., Abdollahi, M.
Publicado em 2010
“... (IMOD) as a mixture of urtica, carotenoids, urea, and selenium has been recently patented for its...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Artigo
74
Por Nidia A. Hernandes, Vanessa S. Probst, Rubens A. Da Silva Jr., Renata S. B. Januário, Fabio Pitta, Denilson C. Teixeira
Publicado no Revista Brasileira de Fisioterapia (2013)
“... for elderly translates into a more active lifestyle. Objectives: To compare the objectively measured level...”Publicado no Revista Brasileira de Fisioterapia (2013)
Obter o texto integral
Artigo
75
Por García-de-Lorenzo, A., Luque, S., Grau, S., Agrifoglio, A., Cachafeiro, L., Herrero, E., Asensio, M. J., Sánchez, S. M., Roberts, J. A.
Publicado no Antimicrob Agents Chemother (2016)
“... the concentration-time curve from 0 to 24 h/MIC cutoffs of 285 for Candida parapsilosis and 3,000 for non...”Publicado no Antimicrob Agents Chemother (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
76
“...Radiotherapy has been the mainstay of the treatment of stage III non-small cell lung cancer (NSCLC...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
77
Por Tabberer, Maggie, Lomas, David A., Birk, Ruby, Brealey, Noushin, Zhu, Chang-Qing, Pascoe, Steve, Locantore, Nicholas, Lipson, David A.
Publicado no Adv Ther (2018)
“...-primary endpoint data have been previously reported. METHODS: FULFIL was a phase III, 24-week, randomized...”Publicado no Adv Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
78
Por Sun, Alexander, Bae, Kyounghwa, Gore, Elizabeth M., Movsas, Benjamin, Wong, Stuart J., Meyers, Christina A., Bonner, James A., Schild, Steven E., Gaspar, Laurie E., Bogart, Jeffery A., Werner-Wasik, Maria, Choy, Hak
Publicado em 2011
“... no overall survival (OS) benefit for PCI in stage III non–small-cell lung cancer (NSCLC) at 1 year. However...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
79
Por Vic, P, Ategbo, S, Turck, D, Husson, M, Launay, V, Loeuille, G, Sardet, A, Deschildre, A, Druon, D, Arrouet-Lagande, C
Publicado em 1998
“... were two to three times higher in group B than group A.
CONCLUSIONS—Once daily tobramycin combined...”Publicado em 1998
Obter o texto integral
Obter o texto integral
Artigo
80
Por Dupoiron, D., Stachowiak, A., Loewenstein, O., Ellery, A., Kremers, W., Bosse, B., Hopp, M.
Publicado no Eur J Pain (2017)
“... and naloxone in a 2:1 ratio. This study aimed to evaluate the tolerability and efficacy of doses up to OXN160...”Publicado no Eur J Pain (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo